세계의 Drug Discovery 서비스 시장 규모, 점유율, 성장 분석, 프로세스별, 유형별, 약물 유형별, 치료 영역별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)

Global Drug Discovery Services Market size was valued at USD 20.10 billion in 2022 and is poised to grow from USD 23.07 billion in 2023 to USD 69.61 billion by 2031, growing at a CAGR of 14.80% during the forecast period (2024-2031).

The Global Drug Discovery Services Market is a rapidly growing sector within the pharmaceutical and biotechnology industries, focused on developing new treatments for various diseases. This market offers a broad range of services that assist in the complex and resource-intensive process of drug discovery. Drug discovery involves identifying and validating potential drug targets, creating drug candidates, and conducting rigorous safety and efficacy testing. Given the high cost and lengthy timelines associated with this process, pharmaceutical and biotech companies increasingly rely on specialized service providers to help streamline and accelerate drug development. These service providers utilize advanced technologies, industry expertise, and infrastructure to optimize drug discovery. Their offerings include target identification and validation, hit identification, lead optimization, medicinal chemistry, as well as in vitro and in vivo testing. They also support preclinical development and early-phase clinical trials. As the demand for innovative therapies continues to rise, the Global Drug Discovery Services Market plays a crucial role in accelerating drug development. With growing investments in research and development, this market is poised for significant expansion in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Services Market Segmental Analysis

Global Drug Discovery Services Market is segmented by Process, Type, Drug Type, Therapeutic Area, and region. Based on Process, the market is segmented into Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, and Candidate Validation. Based on Type, the market is segmented into Chemistry Services, and Biology Services. Based on Drug Type, the market is segmented into Small-Molecule Drugs, and Biologics. Based on Therapeutic Area, the market is segmented into Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Immunological Disorders, Endocrine & Metabolic Disorders, Respiratory Disorders, Digestive System Diseases, Genitourinary Diseases & Women's Health, and Other Therapeutic Areas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Drug Discovery Services Market

The increasing demand for innovative treatments for chronic diseases, along with advancements in the global healthcare sector, are expected to be key drivers of growth in the drug discovery services market. Pharmaceutical and biopharmaceutical companies continue to outsource their research and development (R&D) activities to contract research organizations (CROs), which provide specialized R&D services. These CROs are helping to optimize R&D processes through tailored engagement models, thereby improving efficiency in drug development. The growing burden of chronic diseases has also prompted governments and pharmaceutical companies to seek effective solutions and invest more heavily in clinical trials. This heightened focus on addressing chronic illnesses is driving the need for drug discovery services. As the demand for novel therapies increases, so too will the reliance on these services to support drug development efforts across the healthcare industry.

Restraints in the Global Drug Discovery Services Market

The market is expected to face two significant challenges: a shortage of skilled labor and the high failure rate of target drug molecules. The lack of trained professionals in drug discovery and development could slow down progress, as expertise is critical for advancing complex research and development processes. Additionally, the high failure rate of drug molecules in the early stages of development poses a major hurdle. Pharmaceutical companies invest millions of dollars in preclinical research to identify viable drug candidates, but when these molecules fail to meet expectations, it significantly increases the overall cost of drug development. This not only raises expenses but also adds pressure on the industry to find more efficient solutions.

Market Trends of the Global Drug Discovery Services Market

The Global Drug Discovery Services Market is witnessing several important trends that are shaping its future. One major trend is the growing reliance on outsourcing, as pharmaceutical and biotech companies increasingly turn to specialized service providers for their drug discovery needs. This approach allows companies to leverage external expertise, advanced technology, and cost-effective solutions while concentrating on their core business operations. Another key development is the rise in collaborative partnerships between pharmaceutical companies and contract research organizations (CROs). These alliances promote resource sharing, knowledge exchange, and risk-sharing, driving innovation and speeding up the drug discovery process. Technological advancements are also transforming the drug discovery services market. Cutting-edge technologies like high-throughput screening, artificial intelligence, and genomics are significantly enhancing the drug discovery process. These innovations enable quicker, more precise identification and optimization of drug candidates, leading to more efficient and successful outcomes in the development of new therapies. As a result, these trends are driving growth and fostering further evolution within the industry.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Technology Analysis
• Pricing Analysis
• Customer & Buying Criteria Analysis

Drug Discovery Services Market by Process

• Market Overview
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation

Drug Discovery Services Market by Type

• Market Overview
• Chemistry Services
• Biology Services

Drug Discovery Services Market by Drug Type

• Market Overview
• Small-Molecule Drugs
• Biologics

Drug Discovery Services Market by Therapeutic Area

• Market Overview
• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Neurological Diseases
• Immunological Disorders
• Endocrine & Metabolic Disorders
• Respiratory Disorders
• Digestive System Diseases
• Genitourinary Diseases & Women's Health
• Other Therapeutic Areas

Drug Discovery Services Market by End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
  • Tier 1 Companies
  • Tier 2 Companies
  • Tier 3 Companies
• Academic Institutes
• Other End Users

Drug Discovery Services Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Laboratory Corporation of America Holdings (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi APPTEC (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaron Beijing Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evotec SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Enterprises Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Pharmova Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Holdings Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Medicilon Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurigene Discovery Technologies (Dr. Reddy's Laboratories) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sygnature Discovery Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oncodesign Services (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Selvita S.A. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viva Biotech Holdings (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TCG Lifesciences Pvt Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Chempartner Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Domainex Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvisan Pharma Holding GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dalton Pharma Services (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aragen Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments